Evidence map›Paper›PMID 40208251›Full record

ArticleeLife2025

Adventitial fibroblasts direct smooth muscle cell-state transition in pulmonary vascular disease.

Slaven Crnkovic, Helene Thekkekara Puthenparampil, Shirin Mulch, Valentina Biasin, Nemanja Radic, Jochen Wilhelm, Marek Bartkuhn, Ehsan Bonyadi Rad, Alicja Wawrzen, Ingrid Matzer and 15 more

Abstract read
In one paragraph

Article in eLife, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Loss of lung mesenchymal identities in culture and a screening approach to identify restorative cues.American journal of physiology. Lung cellular and molecular physiology · 2025
    Article
  4. Article
  5. Vascular Remodeling: The Multicellular Mechanisms of Pulmonary Hypertension.International journal of molecular sciences · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Slaven CrnkovicLudwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.ORCID https://orcid.org/0000-0002-0820-3318
Helene Thekkekara PuthenparampilLudwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.
Shirin MulchInstitute for Lung Health, Cardiopulmonary Institute, Member of the German Center for Lung Research, Justus-Liebig University Giessen, Giessen, Germany.
Valentina BiasinLudwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.
Nemanja RadicMedical University of Graz, Lung Research Cluster, Graz, Austria.
Jochen WilhelmInstitute for Lung Health, Cardiopulmonary Institute, Member of the German Center for Lung Research, Justus-Liebig University Giessen, Giessen, Germany.ORCID https://orcid.org/0000-0001-5544-9647
Marek BartkuhnInstitute for Lung Health, Cardiopulmonary Institute, Member of the German Center for Lung Research, Justus-Liebig University Giessen, Giessen, Germany.
Ehsan Bonyadi RadLudwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.
Alicja WawrzenMedical University of Graz, Lung Research Cluster, Graz, Austria.
Ingrid MatzerMedical University of Graz, Lung Research Cluster, Graz, Austria.
Ankita MitraDepartment of Medicine, Stanford University School of Medicine, Stanford, United States.
Ryan D LeibMass Spectrometry Laboratory, Stanford University School of Medicine, Stanford, United States.
Bence Miklos NagyLudwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.
Anita Sahu-OsenLudwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.
Francesco ValzanoLudwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.
Natalie BordagLudwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.
Matthias EvermannMedical University of Vienna, Vienna, Austria.
Konrad HoetzeneckerMedical University of Vienna, Vienna, Austria.
Andrea OlschewskiLudwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.
Senka Ljubojevic-HolzerMedical University of Graz, Lung Research Cluster, Graz, Austria.
Malgorzata WygreckaInstitute for Lung Health, Cardiopulmonary Institute, Member of the German Center for Lung Research, Justus-Liebig University Giessen, Giessen, Germany.ORCID https://orcid.org/0000-0002-3656-2932
Kurt StenmarkDevelopmental Lung Biology and Cardiovascular Pulmonary Research Laboratories, University of Colorado, Aurora, United States.
Leigh M MarshLudwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.ORCID https://orcid.org/0000-0002-1754-9249
Vinicio de Jesus PerezDepartment of Medicine, Stanford University School of Medicine, Stanford, United States.ORCID https://orcid.org/0000-0001-5532-8247
Grazyna KwapiszewskaLudwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.ORCID https://orcid.org/0000-0003-0518-9079

Funding

Austrian Science Fund 10.55776/i4651Cardio-Pulmonary Institute EXC 2026 390649896
6 · The paper itself

Abstract

Background: Pulmonary vascular remodeling is a progressive pathological process characterized by functional alterations within pulmonary artery smooth muscle cells (PASMCs) and adventitial fibroblasts (PAAFs). Mechanisms driving the transition to a diseased phenotype remain elusive. Methods: We combined transcriptomic and proteomic profiling with phenotypic characterization of source-matched cells from healthy controls and individuals with idiopathic pulmonary arterial hypertension (IPAH). Bidirectional cellular crosstalk was examined using direct and indirect co-culture models, and phenotypic responses were assessed via transcriptome analysis. Results: PASMC and PAAF undergo distinct phenotypic shifts during pulmonary vascular remodeling, with limited shared features, such as reduced mitochondrial content and hyperpolarization. IPAH-PASMC exhibit increased glycosaminoglycan production and downregulation of contractile machinery, while IPAH-PAAF display a hyperproliferative phenotype. We identified alterations in extracellular matrix components, including laminin and collagen, alongside pentraxin-3 and hepatocyte growth factor, as potential regulators of PASMC phenotypic transitions mediated by PAAF. Conclusions: While PASMCs and PAAFs retain their core cellular identities, they acquire distinct disease-associated states. These findings provide new insights into the dynamic interplay of pulmonary vascular mesenchymal cells in disease pathogenesis. Funding: This work was supported by Cardio-Pulmonary Institute EXC 2026 390649896 (GK) and Austrian Science Fund (FWF) grant I 4651-B (SC).

Indexed as

AdventitiaFamilial Primary Pulmonary HypertensionFibroblastsMyocytes, Smooth MusclePulmonary ArteryAdultCells, CulturedFemaleHumansMaleVascular Remodelingadventitial fibroblastscell biologyhumanmedicinepulmonary arteryvascular smooth muscle cells

Identifiers

PMID40208251
PMCPMC11984959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.